Landmark coronavirus study to trial inhaled Imperial and Oxford vaccines
UKRI and NIHR funded researchers at Imperial College London are set to begin trials to assess the safety and effectiveness of two of the UK’s coronavirus vaccines in development, when inhaled into the lungs. (Source: Medical Research Council General News)
Source: Medical Research Council General News - September 15, 2020 Category: Research Source Type: news

Study to identify transmission risk of COVID-19 aerosols during medical procedures
Many operations, due to the potential risk of COVID-19 aerosols being generated, have been delayed or are being performed with additional personal protective equipment (PPE), which has greatly reduced NHS services. A new National Institute for Health Research (NIHR) and UK Research and Innovation (UKRI)-funded study will identify which medical procedures are truly aerosol generating and whether the virus remains viable in the aerosol produced. The findings will be crucial in providing guidance about the safe reopening of essential NHS services. (Source: University of Bristol news)
Source: University of Bristol news - September 11, 2020 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news

Angola: Covid-19 - Naturopathic Doctors' Proposal Under Analysis
[ANGOP] Luanda -- The Proposal on Natural Medicine on combat and prevention of covid-19 has been forwarded to the National Institute for Health Research (INIS) Department, aimed at assessing its authenticity and effectiveness. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 9, 2020 Category: African Health Source Type: news

Mental health services and Covid-19: Policy briefing, Centre for Mental Health
The Covid-19 pandemic has had a major impact on the lives of people with mental health difficulties and on mental health services. This briefing identifies key themes from a survey of mental health service staff in the UK and a review of studies across the world. The studies were conducted by the NIHR Mental Health Policy Research Unit (MHPRU) at University College London and King's College London. Its aim is to help the Department of Health and Social Care and others involved in making nationwide plans for mental health services to make decisions based on good evidence. Centre for Mental Health and The Mental Elf work al...
Source: Current Awareness Service for Health (CASH) - September 4, 2020 Category: Consumer Health News Source Type: news

New studies reinforce evidence that corticosteroids improve survival rates among critically ill COVID-19 patients, NIHR
Four papers published today on the use of corticosteroids to treat COVID-19 have reinforced evidence that outcomes for severely affected patients can be significantly improved by using these inexpensive and widely available drugs, with one paper suggesting the risk of death can be reduced by up to 20%. The papers - simultaneously published in the Journal of the American Medical Association (JAMA) - include findings from the REMAP-CAP study being conducted across 15 countries, around the world and for which the NIHR's Clinical Research Network and partner research institutes from devolved nations recruited close to 71% of a...
Source: Current Awareness Service for Health (CASH) - September 2, 2020 Category: Consumer Health News Source Type: news

Mental health and COVID-19, NIHR
The impact of COVID-19 pandemic and the constraints it has imposed on people is an issue of interest and concern to patients, service users, carers and health and social care professionals alike. In pandemic conditions it is likely that people's existing mental health problems may get worse. Mental health may also decline because of social isolation, loss of employment, stress and health anxiety caused by the pandemic and the steps taken to control it. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 2, 2020 Category: Consumer Health News Source Type: news

Prevention of suicide/self-harm in the context of COVID-19, NIHR
Please note all questions within each section are linked to each other and should be read in conjunction. Below each question is the weblink to the source of evidence to support the guidance recommendation. Readers can, of course, focus only on areas of interest, but we would suggest that you read the answers to all questions within a group as the answers complement and overlap with each other. The tables were created with input and guidance from Professor Keith Hawton (Professor of Psychiatry, Centre for Suicide Research, University of Oxford; Consultant Psychiatrist, Oxford Health NHS Foundation Trust), Dr Alexandra Pit...
Source: Current Awareness Service for Health (CASH) - September 2, 2020 Category: Consumer Health News Source Type: news

Unprecedented national effort by UK immunologists to search for answers on COVID-19
Three new UK-wide studies, bringing together scientists from 17 research institutions, will receive£8.4 million from UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR) to understand immune responses to the novel coronavirus. (Source: Medical Research Council General News)
Source: Medical Research Council General News - August 29, 2020 Category: Research Source Type: news

High rates of delirium, persistent fatigue and post-traumatic stress disorder were common after severe infection in previous coronavirus outbreaks, NIHR
Little is known about the mental health consequences of severe COVID-19 illness because it is caused by a new coronavirus. Previous outbreaks caused by other coronaviruses (severe acute respiratory syndrome, SARS, and Middle East respiratory syndrome, MERS) may provide insights into ongoing problems after recovery from severe illness. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 28, 2020 Category: Consumer Health News Source Type: news

Negative-pressure wound therapy compared with standard dressings following surgical treatment of major trauma to the lower limb: the WHiST RCT , NIHR
This UK study (n=1548) found no evidence of a difference between negative pressure wound therapy and standard dressings in rate of deep surgical site infection, disability, quality of life or scar appearance in patients having surgery for major trauma to the limbs. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 24, 2020 Category: Consumer Health News Source Type: news

Childhood syndrome linked to COVID-19 causes profound immune changes
(National Institute for Health Research) Researchers have uncovered how the immune system is altered in a rare COVID-19 related illness in children referred to as paediatric inflammatory multisystem syndrome (PIMS-TS). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 18, 2020 Category: Infectious Diseases Source Type: news

Digital technologies and telepsychiatry, NIHR
The following table is divided into four: Table A is short and concise, and is designed for quick reference, with practical advice summarised briefly as a checklist for busy clinicians. Tables B, C and D have full detail and cover the different implications and possibilities for using telepsychiatry in general, in children and adolescents and in older adults. In Tables B, C and D, questions are arranged in groups covering topics listed under headings. Readers can, of course, focus only on areas of interest, but we would suggest that you read the answers to all questions within a group as the answers complement and overlap ...
Source: Current Awareness Service for Health (CASH) - August 17, 2020 Category: Consumer Health News Source Type: news

Early warning scores used in hospitals must be based on sound science, NIHR (published 14th August 2020)
An expert commentary is provided on a review that found many early warning scores are based on flawed research. NEWS 2, endorsed by NHS England and NHS Improvement, is a modification of the original NEWS; the study found the latter was not derived using robust statistical methods. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 17, 2020 Category: Consumer Health News Source Type: news

High rates of delirium, persistent fatigue and post-traumatic stress disorder were common after severe infection in previous coronavirus outbreaks, NIHR
Little is known about the mental health consequences of severe COVID-19 illness because it is caused by a new coronavirus. Previous outbreaks caused by other coronaviruses (severe acute respiratory syndrome, SARS, and Middle East respiratory syndrome, MERS) may provide insights into ongoing problems after recovery from severe illness. Researchers looked at reports of psychiatric problems during SARS and MERS outbreaks and compared this to early data from the COVID-19 pandemic. Delirium (sudden confusion) was common while patients were in hospital with any of the coronavirus infections (SARS, MERS or COVID-19). Later, once ...
Source: Current Awareness Service for Health (CASH) - August 13, 2020 Category: Consumer Health News Source Type: news

Multimillion investment in new research projects to investigate higher COVID-19 risk among certain ethnic groups, NIHR
Six new projects to improve our understanding of the links between COVID-19 and ethnicity have been funded by the NIHR and UK Research and Innovation (UKRI). These projects will seek to explain and mitigate the disproportionate death rate from COVID-19 among people from Black, Asian and minority ethnic (BAME) backgrounds, including BAME health and social care workers. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 13, 2020 Category: Consumer Health News Source Type: news

Cochrane Acute and Emergency Care Network seeks Network Support Fellow
Contract: Fixed-term, 12 monthsHours: Full time, 37.5 per week (part time considered)Salary:  £31,365 - £37,890 per annum pro rata (dependent on experience)Position Closing: 20 August 2020Cochrane Acute and Emergency Care Network is seeking a Network Support Fellow. Cochrane is a global, independent network of health practitioners, researchers, patient advocates and others, responding to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesizing research findings to produce the best available evidence on what can work, what might harm a...
Source: Cochrane News and Events - August 6, 2020 Category: Information Technology Authors: Rachel Klabunde Source Type: news

Multimillion investment in six new research projects to investigate COVID-19 and ethnicity
Six new projects to improve our understanding of the links between COVID-19 and ethnicity have been funded by UK Research and Innovation’s (UKRI) Medical Research Council (MRC) and the National Institute for Health Research (NIHR). (Source: Medical Research Council General News)
Source: Medical Research Council General News - July 29, 2020 Category: Research Source Type: news

Can wearables like Fitbit devices be used to help detect COVID-19?
(NIHR Maudsley Biomedical Research Centre) The COVID-Collab research team at King's College London have launched a free mobile app [Android] [iOS] which will allow scientists to investigate the use of wearable devices and smartphones for digital detection of COVID-19, to understand how it spreads and how the pandemic affects people's mental and physical health. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 24, 2020 Category: International Medicine & Public Health Source Type: news

Collecting rapid COVID-19 intelligence to improve primary care response, NIHR
Project aims To identify the changing demands on GP practices across Bristol, North Somerset and South Gloucestershire during the COVID-19 pandemic and investigate common challenges and innovative solutions that practices have devised to cope with this. Anticipated impacts The project will help us understand how GP practices respond to the pandemic in the way they manage demand and implement alternatives to face-to-face consultations. This information will be rapidly fed back to various practices, commissioners and policy makers to help them to support GP practices in safely delivering care to patients during the curren...
Source: Current Awareness Service for Health (CASH) - July 23, 2020 Category: Consumer Health News Source Type: news

Drug users who lack access to clean water use dangerous alternatives to prepare injections, NIHR Alert
Expert commentary is provided on study exploring how people who inject drugs typically prepare injections, including when they are homeless. Researchers found many had resorted to using puddle water, alcoholic drinks and even saliva when unable to access clean water for injecting (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 22, 2020 Category: Consumer Health News Source Type: news

First trial results show UK coronavirus vaccine produces a strong immune response, NIHR
A new experimental vaccine for coronavirus causes induces strong immune responses in both parts of the immune system and cause few mild side effects, in promising results from a trial funded and supported by the NIHR. The results of the early trial, published in The Lancet, show that the ChAdOx1 nCoV-19 vaccine generated strong immune responses in both parts of the immune system, activating white blood cells that can attack cells infected with the SARS-CoV-2 virus, and antibodies that find and attack the virus when it's circulating in the blood or lymphatic system. The researchers also found that immune responses may be ev...
Source: Current Awareness Service for Health (CASH) - July 21, 2020 Category: Consumer Health News Source Type: news

COVID-19 & clinical management of mental health issues: Evidence-based guidance (updated 15th July 2020), NIHR
COVID-19 is spreading fast around the world. Mental health patients and their clinicians need rapid access to evidence-based information to help to guide their shared decision-making. Here, we summarise the best available clinical guidelines about key COVID-19 questions that frontline mental health professionals are facing every day. This is not a legal or NHS approved document, but we have followed a rigorous methodological approach to search and select the information needed to answer these specific questions. This webpage is a guidance for busy clinicians, organised around specific clinical questions and derived from ex...
Source: Current Awareness Service for Health (CASH) - July 16, 2020 Category: Consumer Health News Source Type: news

World-leading study into long-term health impacts of COVID-19 launched by UKRI and NIHR
Today, UKRI and NIHR are announcing£8.4 million funding for one of the world’s largest studies into the long-term physical and mental health impacts of coronavirus on hospitalised patients.  (Source: Medical Research Council General News)
Source: Medical Research Council General News - July 6, 2020 Category: Research Source Type: news

COVID-19 & clinical management of mental health issues, NIHR
Here, we summarise the best available clinical guidelines about key COVID-19 questions that frontline mental health professionals are facing every day. This is not a legal or NHS approved document, but we have followed a rigorous methodological approach to search and select the information needed to answer these specific questions. (updated 29th June) (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 3, 2020 Category: Consumer Health News Source Type: news

Obese BME people at 'higher-risk' of contracting COVID-19
(National Institute for Health Research) Obese people among black and minority ethnic communities (BME) are at around two times higher the risk of contracting COVID-19 than white Europeans, a study conducted by a team of Leicester researchers has found. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 3, 2020 Category: Infectious Diseases Source Type: news

Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation, NIHR
Review of 21 point-of-care tests (POCTs) identified 38 studies of clinical-and 3 studies of cost-effectiveness, and found sensitivity and specificity estimates are promising, but there is little information to establish most accurate PCOT in primary/secondary care settings. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 2, 2020 Category: Consumer Health News Source Type: news

How to manage patients on lithium during the COVID-19 pandemic, NIHR
How to manage patients on lithium during the COVID-19 pandemic. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 1, 2020 Category: Consumer Health News Source Type: news

How to manage patients on long-acting injectable (LAI, or depot) antipsychotics during the COVID-19 pandemic, NIHR
This guidance includes information about LAI antipsychotic medications which are currently licensed in the UK (that is: Xeplion ® , Trevicta ® , Abilify Maintena ® , Risperdal Consta ® , Zypadhera ® ) (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 1, 2020 Category: Consumer Health News Source Type: news

How to manage patients on benzodiazepines and Z-drugs during the COVID 19 pandemic, NIHR
Benzodiazepines and Z-drugs (Zopiclone and Zolpidem) have the capacity to depress respiratory drive, so they should be used with caution in patients with evidence of compromised respiratory function (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 1, 2020 Category: Consumer Health News Source Type: news

NIHR Alert: Public health messages on alcohol need to consider how and why people drink, not just how much, NIHR Evidence
Commentaries are provided on interviews conducted on 22 adults in North East England. Researchers found that people often thought harmful drinking was less about the quantity consumed and more about a person's emotional relationship with alcohol. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 24, 2020 Category: Consumer Health News Source Type: news

UK to launch world's largest genetic study into chronic fatigue syndrome
Research aims to shine a light on condition that is believed to affect 250,000 people in UKThe world ’s largest genetic study into chronic fatigue syndrome is to be launched in the UK after receiving £3.2m of funding from the Medical Research Council and National Institute for Health Research.The research aims to shine a light on the debilitating long-term condition, about which little is known, by collecting DNA samples from 20,000 people who have CFS, also known as myalgic encephalomyelitis (ME).Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 23, 2020 Category: Science Authors: Haroon Siddique Tags: ME / Chronic fatigue syndrome Medical research Health Science UK news Society Source Type: news

First volunteer receives new COVID-19 vaccine today
The first healthy volunteer has now received a new coronavirus vaccine developed by researchers led by Professor Robin Shattock at Imperial College London. The phase I trials were funded by UKRI as part of the UKRI/DHSC/NIHR COVID-19 rapid research response. (Source: Medical Research Council General News)
Source: Medical Research Council General News - June 23, 2020 Category: Research Source Type: news

First drug to reduce mortality in hospitalised patients with respiratory complications of COVID-19 found, NIHR: Oxford Health Biomedical Research Centre
The NIHR-funded and supported study RECOVERY (Randomised Evaluation of COVid-19 thERapY) has today announced that the steroid dexamethasone has been identified as the first drug to improve survival rates in certain coronavirus patients. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 17, 2020 Category: Consumer Health News Source Type: news

Therapists and patients have good quality interactions during telephone sessions, NIHR: Oxford Health Biomedical Research Centre
The quality of interactions between therapists and their patients is as good by telephone as in face-to-face sessions. A review of the evidence found little difference in the interaction regardless of how therapy was delivered. Telephone sessions were shorter but measures such as empathy and attentiveness, as well as patients'readiness to disclose information, was similar in both settings. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 17, 2020 Category: Consumer Health News Source Type: news

UKRI and NIHR move to new phase of COVID-19 research funding
To meet the needs of this new environment, the NIHR/UKRI rolling call will close to new applications on 30 June 2020. The NIHR has launched a new‘Recovery and Learning’ callto better understand and manage the health and social care consequences of the global COVID-19 pandemic. (Source: Medical Research Council General News)
Source: Medical Research Council General News - June 16, 2020 Category: Research Source Type: news

COVID-19 & clinical management of mental health issues, NIHR: Oxford Health Biomedical Research Centre
Summary of the best available guidance about key COVID-19 questions that frontline mental health clinicians are facing every day. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 15, 2020 Category: Consumer Health News Source Type: news

Guide to COVID-19 clinical evidence generation launched by NIHR and NICE
The NIHR and NICE have developed a guide on clinical evidence generation for developers of medicinal products for COVID-19. The aim is to promote the highest standards possible within the constraints of the pandemic in terms of registration, conduct and reporting of studies, so that research on new treatments can be translated into clinical practice as fast as possible. The guide covers both confirmatory trials and real-world evidence collection on disease treatment and prevention, outlining the best practice approaches to a range of issues including trial design, population identification, the length of the trial and tria...
Source: Current Awareness Service for Health (CASH) - June 12, 2020 Category: Consumer Health News Source Type: news

Research begins to rapidly understand deadly link between Covid-19 and cardiovascular diseases
Improved care for people with heart and circulatory disease suffering from COVID-19 could soon be available after the British Heart Foundation (BHF) and National Institute for Health Research (NIHR) announced support for six flagship research programmes. Researchers from across the UK including the University of Bristol will combine data from hospitals, information about our health and lifestyle, genetic studies, and cutting-edge imaging and artificial intelligence techniques to better understand how the virus affects the heart and circulatory system. (Source: University of Bristol news)
Source: University of Bristol news - June 12, 2020 Category: Universities & Medical Training Tags: Research, Health, Grants and Awards; Institutes, ALSPAC, Institutes, Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news

COVID-19 & clinical management of mental health issues , NIHR: Oxford Health Biomedical Research Centre
Summary of the best available guidance about key COVID-19 questions that frontline mental health clinicians are facing every day. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 8, 2020 Category: Consumer Health News Source Type: news

Social prescribing could empower patients to address non-medical problems in their lives, NIHR
NIHR Evidence. Many GP practices are exploring social prescribing, which is a way of linking patients to sources of support in the local community. Social prescribing addresses non-medical needs such as loneliness and financial difficulties. The NHS employs link workers to connect patients with local support networks. During the COVID-19 crisis, link workers may have an even greater role to play in supporting vulnerable patients who are isolated at home. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 29, 2020 Category: Consumer Health News Source Type: news

NIHR Alert: Largest ever trial into a rare cancer of the urinary system shows clear benefits of chemotherapy after surgery, NIHR Evidence
The largest trial ever conducted into the disease found that giving chemotherapy halves the risk of the cancer coming back after surgery. The results provide clear evidence for this approach to become the new standard of care for patients whose disease has not spread to other parts of the body. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 27, 2020 Category: Consumer Health News Source Type: news

£ 7 million government investment in Patient Recruitment Centres for commercial clinical research
(National Institute for Health Research) The new research centres will increase capacity within the NHS to deliver vital research for patients, while decreasing the time it takes to set-up late-phase commercial trials within the NHS -- improving the UK's competitiveness in the global market and providing opportunities for patients to benefit from early access to innovation. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 22, 2020 Category: Infectious Diseases Source Type: news

Cochrane identifies its priority areas for future COVID-19 work and lists other critical questions for the research community
Cochrane today announces itsCOVID-19 priority areas of work over the next six months to help meet the healthcare evidence needs of policymakers, guideline developers and clinicians; and makes available a list of additional priority questions to help guide the work of other research organizations.Since 18 March, Cochrane has been gathering some of the most important questions related to the COVID-19 pandemic from health researchers, clinicians, policymakers, patients and carers, as well as important external stakeholders including theWorld Health Organization (WHO), the UK National Institute for Health Research&nb...
Source: Cochrane News and Events - May 21, 2020 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Cognitive behavioural therapy reduces the impact of dissociative seizures
(NIHR Maudsley Biomedical Research Centre) Scientists have found that adding cognitive behavioral therapy (CBT) to standardized medical care gives patients with dissociative seizures longer periods of seizure freedom, less bothersome seizures and a greater quality of life, in a study published in Lancet Psychiatry today and by the Cognitive behavioral therapy for adults with dissociative seizures (CODES) study group funded by National Institute for Health Research (NIHR). (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 20, 2020 Category: International Medicine & Public Health Source Type: news

Could a drug combination prevent people with the eye disease uveitis lose their sight?
Two in 10,000 people are at risk of serious sight loss from a form of eye inflammation known as uveitis. A new clinical research study, led by the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), will evaluate a drug combination treatment for the eye disease thanks to funding of £ 2.5 million by the National Institute for Health Research (NIHR). The study will be co-ordinated by the University's Bristol Trials Centre (CTEU). (Source: University of Bristol news)
Source: University of Bristol news - May 12, 2020 Category: Universities & Medical Training Tags: Grants and Awards, Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Translational Health Sciences; Press Release Source Type: news

Could a drug combination prevent people with the eye disease uveitis lose their sight?
(University of Bristol) Two in 10,000 people are at risk of serious sight loss from a form of eye inflammation known as uveitis. A new clinical research study, led by the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), will evaluate a drug combination treatment for the eye disease thanks to funding of £ 2.5 million by the National Institute for Health Research (NIHR). The study will be co-ordinated by the University's Bristol Trials Centre (CTEU). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 12, 2020 Category: International Medicine & Public Health Source Type: news

New call for research on the risk factors, transmission and prevalence of coronavirus
A new call for research proposals on the risk factors, transmission and prevalence of the COVID-19 virus SARS-CoV-2, has been launch by UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR). (Source: Medical Research Council General News)
Source: Medical Research Council General News - May 7, 2020 Category: Research Source Type: news

Bristol researchers contribute to COVID-19 rapid evidence reviews
Researchers from across the University of Bristol are contributing to COVID-19 rapid evidence reviews, co-ordinated by the National Institute for Health Research Applied Research Collaboration West (NIHR ARC West). (Source: University of Bristol news)
Source: University of Bristol news - May 4, 2020 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Faculty of Health Sciences, Population Health Sciences; Press Release Source Type: news

COVID-19 vaccine begins human trial stage
Researchers at the University of Oxford have begun testing a COVID-19 vaccine in human volunteers this week. The phase I trial was funded by UKRI and NIHR as part of the rapid research response. (Source: Medical Research Council General News)
Source: Medical Research Council General News - April 24, 2020 Category: Research Source Type: news